Skip to main content
. 2023 May 14;29(18):2836–2849. doi: 10.3748/wjg.v29.i18.2836

Figure 3.

Figure 3

The immunohistory results. A: A de novo colorectal cancer (CRC) pathological section stained with E-cad and vimentin (VIM); B: A carcinoma in adenoma CRC pathological section stained with E-cad and VIM. VIM: Vimentin.